The success of copyright’s blockbuster initially fueled a period of growth for pharma, nevertheless recent changes present a murky outlook for investors. Off-patent alternatives are eroding revenue, and persistent https://lanceqnqx116275.eedblog.com/41458029/viagra-and-big-pharma-a-risky-bet